S
Sunshine Biopharma, Inc. (SBFM)
NCM – Real Time Price. Currency in USD
2.18
+0.04 (1.87%)
At close: Jun 26, 2026, 4:00 PM EDT
2.08
-0.10 (-4.59%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.18
+0.04 (1.87%)
At close: Jun 26, 2026, 4:00 PM EDT
2.08
-0.10 (-4.59%)
After-hours: Jun 26, 2026, 7:49 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $6.9M significantly exceed its total debt $744.8K, ensuring strong financial flexibility
Total current assets $24.8M exceed Total current liabilities $5.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.22 | 2.52 | 10 | |
| Quick ratio | 1.98 | 1.78 | 9.0 | |
| Debt to Equity | 0.03 | -0.80 | 9.0 | |
| Debt to Assets | 0.03 | 0.73 | 9.0 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 24M | 35M | 36M | 35M |
| Gross Profit | 2M | 8M | 10M | 12M | 11M |
| Operating Income | -9M | -5M | -6M | -4M | -5M |
| Net Income | -27M | -5M | -5M | -6M | -6M |
| EBITDA | -9M | -5M | -6M | -4M | -4M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -7.55 | 69.23 | 5.5 |
| Next quarter | -3.37 | 89.47 | 5.5 |
| Current year | -2.48 | 56.25 | 5.5 |
| Next year | 27.12 | 103.17 | 10 |
| Weighted average score | 6.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -5.68 | 41.9 | 16.67 | -28.61 | 5.3 |
| Y/Y | -9.12 | -5.42 | 43.18 | -22 | 3.3 |
| 3y average | 167.76 | 17.61 | 89.2 | -20.54 | 7.5 |
| 5y average | 505.11 | -81.77 | N/A | -87.38 | 3.3 |
| Weighted average score | 4.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |